Svizzera - francese - Swissmedic (Swiss Agency for Therapeutic Products)

curatis ag - polyestradioli phosphas, mepivacaini hydrochloridum - injektionspräparat - préparation cryodesiccata: polyestradioli phosphas 80 mg, mepivacaini hydrochloridum 5 mg, nicotinamidum, dinatrii phosphas dihydricus, natrii hydroxidum, pour le verre. libérer: de l'eau pour iniectabilia de 2 ml. - cancer de la prostate - synthetika

Svizzera - francese - Swissmedic (Swiss Agency for Therapeutic Products)

curatis ag - tetracosactidum - solution injectable - tetracosactidum 0.25 mg ut tetracosactidi hexaacetas, acidum aceticum glaciale, natrii acetas trihydricus, natrii chloridum, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium 3.34 mg. - diagnostic fonctionnel nnr; acth-thérapie - synthetika

Svizzera - francese - Swissmedic (Swiss Agency for Therapeutic Products)

curatis ag - tetracosactidum - suspension injectable - tetracosactidum 1 mg ut tetracosactidi hexaacetas, zinci chloridum, alcohol benzylicus 10 mg, natrii chloridum, dinatrii phosphas dodecahydricus, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile ad suspensionem pro 1 ml corresp. natrium 1.1 mg. - acth-thérapie; diagnostic fonctionnel nnr - synthetika

Svizzera - francese - Swissmedic (Swiss Agency for Therapeutic Products)

curatis ag - aldesleukinum - poudre pour solution à diluer pour perfusion - praeparatio cryodesiccata: aldesleukinum 18 mio u.i., mannitolum, natrii laurilsulfas, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dihydricus, pro vitro corresp. natrium 0.40 mg. - metastasierendes nierenkarzinom - biotechnologika

Svizzera - francese - Swissmedic (Swiss Agency for Therapeutic Products)

curatis ag - interferonum humanum gamma-1b adnr - solution injectable - interferonum humanum gamma-1b adnr 0.10 mg, mannitolum, dinatrii succinas hexahydricus corresp. natrium 0.06 mg, acidum succinicum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. - granulomatose chronique - biotechnologika

Svizzera - francese - Swissmedic (Swiss Agency for Therapeutic Products)

curatis ag - tirofibanum - solution à diluer pour perfusion - tirofibanum 12.5 mg ut tirofibani hydrochloridum monohydricum, natrii chloridum, natrii citras dihydricus, acidum citricum, aqua ad iniectabile q.s. ad solutionem pro 250 ml. - inhibiteur de l'agrégation plaquettaire - synthetika

Svizzera - francese - Swissmedic (Swiss Agency for Therapeutic Products)

curatis ag - lyophilisat

Svizzera - francese - Swissmedic (Swiss Agency for Therapeutic Products)

curatis ag - digitalis antitoxinum ovis fab - lyophilisat - digitalis antitoxinum moutons fab 36 à 44 mg, natrii acetas, l'acide aceticum, mannitolum, pour la préparation. - antidote à la vie en danger digitalisvergiftungen - antidota

Svizzera - francese - Swissmedic (Swiss Agency for Therapeutic Products)

curatis ag - vernakalantum - solution à diluer pour perfusion - vernakalanti hydrochloridum 500 mg corresp. vernakalantum 452.5 mg, acidum citricum monohydricum, natrii chloridum, natrii hydroxidum, aqua ad iniectabile ad solutionem pro 25 ml corresp. natrium 78.75 mg. - antiarrhythmikum - synthetika

Svizzera - francese - Swissmedic (Swiss Agency for Therapeutic Products)

curatis ag - succimerum - capsules - succimerum 200.54 mg, lactosum monohydricum 139.58 mg, silica colloidalis anhydrica, magnesii stearas, kapselhülle: gelatina, e 171, glycerolum, pro capsula. - antidote, métaux lourds - antidota